EUVIMEDEUVIMED entdecken
Open Access

Baicalein inhibits IL-1β-induced extracellular matrix degradation with decreased MCP-1 expression in primary rat chondrocytes

InA Cho, Ki-Ho Chung, Young Kim, Choong-Ho Choi, Jeong-Tae Koh iD

Toxicological Research · 2024-04 · 40 (2) · 237-246

DOI: 10.1007/s43188-024-00225-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxicological Research, online erschienen am 02.02.2024. Verfasst von InA Cho und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Dental Therapeutics, School of Dentistry, Chonnam National University, Gwangju, 61186 Republic of Korea. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Research Foundation of Korea, Korean Fund for Regenerative Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Baicalein is a flavonoid extracted from the roots of Scutellaria baicalensis and Scutellaria lateriflora. This compound exerts various biochemical activities, including antioxidant and anti-inflammatory effects. The study aimed to investigate the effect of baicalein on articular cartilage cells and elucidate its underlying mechanism. In primary rat chondrocyte cultures, treatment with baicalein demonstrated a reduction in the loss of proteoglycan and extracellular matrix degradation induced by interleukin (IL)-1β. Baicalein suppressed IL-1β-induced catabolic responses, including the expression and activation of matrix metalloproteinase (MMP)-13, MMP-3, and MMP-1. In addition, baicalein effectively reduced nitric oxide and prostaglandin E2 production, and it downregulated the expression of inducible nitric oxide synthase and cyclooxygenase-2 in primary rat chondrocytes. Furthermore, baicalein downregulated IL-1β-induced inflammatory chemokines and cytokines, such as GM-CSF and MCP-1. These findings suggest that baicalein could potentially mitigate the catabolic responses of IL-1β in chondrocytes, making it a promising candidate for both the prevention and treatment of osteoarthritis. Supplementary Information: The online version contains supplementary material available at 10.1007/s43188-024-00225-4.

Schlagwörter

Stichwörter der Autor:innen

BaicaleinChondrocytesIL-1βMCP-1Matrix metalloproteinases

Autor:innen und Institutionen

  • Department of Pharmacology and Dental Therapeutics, School of Dentistry, Chonnam National University, Gwangju, 61186 Republic of Korea.
  • Hard-Tissue Biointerface Research Center, School of Dentistry, Chonnam National University, Gwangju, 61186 Republic of Korea.
  • Department of Preventive and Public Health Dentistry, School of Dentistry, Chonnam National University, Gwangju, 61186 Republic of Korea.
  • Department of Oral Pathology, School of Dentistry, Chonnam National University, Gwangju, 61186 Republic of Korea.

ORCID-Profile: Jeong-Tae Koh

Förderung

  • National Research Foundation of Korea
  • Korean Fund for Regenerative Medicine

Zitieren

APA

Cho, I., Chung, K. H., Kim, Y., Choi, C. H., & Koh, J. T. (2024). Baicalein inhibits IL-1β-induced extracellular matrix degradation with decreased MCP-1 expression in primary rat chondrocytes. Toxicological Research, 40(2), 237-246. https://doi.org/10.1007/s43188-024-00225-4

Vancouver

Cho I, Chung KH, Kim Y, Choi CH, Koh JT. Baicalein inhibits IL-1β-induced extracellular matrix degradation with decreased MCP-1 expression in primary rat chondrocytes. Toxicological Research. 2024;40(2):237-246. doi:10.1007/s43188-024-00225-4

BibTeX
@article{Cho2024,
  author = {Cho, InA and Chung, Ki-Ho and Kim, Young and Choi, Choong-Ho and Koh, Jeong-Tae},
  title = {Baicalein inhibits IL-1β-induced extracellular matrix degradation with decreased MCP-1 expression in primary rat chondrocytes},
  journal = {Toxicological Research},
  year = {2024},
  volume = {40},
  number = {2},
  pages = {237--246},
  doi = {10.1007/s43188-024-00225-4}
}
Kostenlos starten →